A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer

International Journal of Cancer

Volumn 70, Issue 3, 1997, Pages 269-277

  Veelken, Hendrik ^a   Mackensen, Andreas ^a   Lahn, Michael ^a   Köhler, Gabriele ^a   Becker, Daniel ^a   Franke, Brigitte ^a   Brennscheidt, Ulrich ^a   Kulmburg, Peter ^a   Rosenthal, Felicia M ^a   Keller, Helmut ^a   Hasse, Joachim ^a   Schultze Seemann, Wolfgang ^a   Farthmann, Eduard H ^a   MertelsmanN', Roland ^a   Lindemann, Albrecht ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERLEUKIN 2;

ARTICLE; AUTOGRAFT; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; INFLAMMATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION; TUMOR CELL;

ADULT; AGED; CANCER VACCINES; CELL SEPARATION; DISEASE PROGRESSION; FEASIBILITY STUDIES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERLEUKIN-2; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; NEOPLASMS; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 0031053562     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970127)70:3<269::AID-IJC4>3.0.CO;2-V     Document Type: Article

References (22)

1. BOON, T., CEROTTINI, J.-C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994).
2. CORDELL, J.L., FALINT, B., ERBER, W.N., GHOSH, A.K., ABDULAZIZ, Z., MACDONALD, S., PULFORD, K.A., STEIN, H. and MASON, D.Y., Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem., 32, 219-229 (1984).
3. GOTTEN, M., BAKER, A., SALTIK, M., WAGNER, E. and BUSCHLE, M., Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary cells in the presence of adenovirus. Gene Ther., 1, 239-246 (1994).
4. FAKHRAI, H., SHAWLER, D.L., GJERSET, R., NAVIAUX, R.K., KOZIOL, J., ROYSTON, I. and SOBOL, R., Cytokine gene therapy with interleukin-2transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity. Hum. Gene Ther., 6, 591-601 (1995).
5. FATHMAN, C.G., Stimulating the lymphocytes. Curr. Biol., 3, 558-559 (1993).
6. JANEWAY, C.A. and BOTTOMLY, K., Signals and signs for lymphocyte responses. Cell, 76, 275-285 (1994).
7. LUNA-FINEMAN, S., LEE, J.E., WESLEY, P.K., CLAYBERGER, C., and KRENSKY, A.M., Human cytotoxic T lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major hislocompatibility complex restricted fashion. Cancer, 70, 2181-2186 (1992).
8. MACKENSEN, A., CARCELAIN, G., VIEL, S., RAYNAL, M.C., MICHALAKI, H., TRIEBEL, F., BOSQ, J. and HERCEND, T., Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. clin. Invest., 93, 1397-1402 (1994).
9. MACKENSEN, A., FERRADINI, L., CARCELAIN, G. TRIEBEL, F., FAURE, F., VIEL, S. and HERCEND, T., Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res., 53, 3569-3573 (1993).
10. MACKENSEN, A., HERBST, B., KÖHLER, G., WOLFE-VORBECK, G., ROSENTHAL, P.M., VEELKEN, H., KULMBURG, P., SCHAEFER, H.E., MERTELSMANN, R. and LINDEMANN, A., Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood, 86, 2699-2707 (1995).
11. MERTELSMANN, R., LINDEMANN, A., BOEHM, T., BRENNSCHEIDT, U., FRANKE, B., KULMBURG, P., LAHN, M., MACKENSEN, A., ROSENTHAL, F.M. and VEELKEN, H., Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors. J. mol. Med., 73, 205-206 (1995).
12. 60Co gamma rays. Int. J. Cancer, 35, 275-280 (1985).
13. NEHLS, M.C., KRAUSE, S. and BOEHM, T., Neomycin- and hygromycin-resistance expression cassettes containing an artificial triple-helix-site and a synthetic lac operator facilitate restriction endonuclease cleavage at predefined sites and recovery of specific fragments from mammalian genomes. Mamm. Genome, 5, 183-186 (1994).
14. PANTEL, K., DICKMANNS, A., ZIPPELIUS, A., KLEIN, C., SHI, J., HOECHTLEIN-- VOLLMAR, W., SCHLIMOK, G., WECKERMANN, D., OBERNEDER, R., FANNING, E. and RIETHMULLER, G., Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J. nal. Cancer Inst., 87, 1162-1168 (1995).
15. PEOPLES, G.E., GOEDGEBUURE, P.S., SMITH, R., LINEHAN, D.C., YOSHINO, I. and EBERLEIN, T.J., Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc. nat. Acad. Sci. (Wash.), 92, 432-436 (1995).
16. PLAUTZ, G.E., YANG, Z.Y., Wu, B.Y., GAO, X., HUANG, L. and NABEL, G.J., Immunotherapy of malignancy by m vivo gene transfer into tumors. Proc. not. Acad. Sci. (Wash.), 90, 4645-4649 (1993).
17. ROEHM, N.W., RODGERS, G.H., HATFIELD, S.M. and GLASERBROOK, A.L., An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. immunol Meth., 142, 257-265 (1991).
18. SCHENDEL, D.J., GANSBACHER, B., OBERNEDER, R., KRIEGMAIR, M., HOFSTETTER, A., RIETHMULLER, G. and SEGURADO, O.G., Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic cell lines. J. Immunol., 151, 4209-4220 (1993).
19. SELDEN, R.F., SKOSKIEWICZ, M.J., RUSSELL, P.S. and GOODMAN, H.M., Regulation of insulin-gene expression. Implications for therapy. New Engl. J. Med., 317, 1067-1076 (1987).
20. TAHARA, H., ZEH, H.J., STORKUS, W.J., PAPPO, I., WATKINS, S.C., GUBLER, U., WOLF, S.F., ROBBINS, P.D. and LOTZE, M.T., Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res., 54, 182-189 (1994).
21. TEPPER, R.I. and MULÉ, J.J., Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther., 5, 153-164 (1994).
22. VEELKEN, H., JESUITER, H., MACKENSEN, A., KULMBURG, P., SCHULTZE, J., ROSENTHAL, F., MERELSMANN, R. and LINDEMANN, A., Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy. Hum. Gene Ther., 5, 1203-1210 (1994).